test
testing images
Listen to this article
Stay ahead of every shift in generics and biosimilars.
More from Strategy
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
More from Leadership
Biocon has made two key appointments to the management team of Biocon Biologics following a recent change in CEO for the biosimilars business.